Stage‐dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|9|2369-2382

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.9, 2015-05, pp. : 2369-2382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 30, Iss. 4, 2015-08 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relation of Epicardial Fat Thickness to the Severity of Heart Failure in Patients with Nonischemic Dilated Cardiomyopathy

By  

ECHOCARDIOGRAPHY (ELECTRONIC), Vol. 32, Iss. 5, 2015-05 ,pp. : 740-748

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parent reports of health-related quality of life and heart failure severity score independently predict outcome in children with dilated cardiomyopathy

By  

Cardiology in the Young, Vol. 27, Iss. 6, 2017-03 ,pp. : 1194-1202

Cambridge University Press

Access to resources Recommend Favorite

Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 1, 2014-01 ,pp. : 109-114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Benefits and risks of success or failure of noninvasive ventilation

By Demoule Alexandre   Girou Emmanuelle   Richard Jean-Christophe   Taille Solenne   Brochard Laurent  

Intensive Care Medicine, Vol. 32, Iss. 11, 2006-11 ,pp. : 1756-1765

Springer Publishing Company

Access to resources Recommend Favorite